J.P. Morgan Notebook Day 4: US Generics Steady, UroGen, REGENXBIO, Dr. Reddy's In China, And Investor Sentiment Shifts

10 Jan 2019

• By Emily Hayes, Mandy Jackson, Jessica Merrill, Mike Ward, and Anju Ghangurde

Daily round-up of news and notes from the 2019 J.P. Morgan Healthcare Conference in San Francisco: US generics see gains, researcher calls for more tech transfer, and biotech investor sentiment rises as big deals bring optimism – among other items from the last day of this year's JPM.

San Francisco, California, United States - August 17, 2016: The Cable Car of San Francisco full of tourists in front of luxurious Westin St. Francis hotel, along the famous Powell Street. - Image

J.P. Morgan Notebook Day 4: US Generics Steady, UroGen, REGENXBIO, Dr. Reddy's In China, And Investor Sentiment Shifts

More from Cell & Gene Therapies

More from Advanced Technologies